The promiscuity of immunoglobulin E binding to peanut allergens, as determined by Western blotting, correlates with the severity of clinical symptoms
The promiscuity of immunoglobulin E binding to peanut allergens, as determined by Western blotting, correlates with the severity of clinical symptoms
Background IgE binding to a specific protein has been shown to be associated with severe anaphylaxis to hazelnuts; however, the relationship between IgE binding to specific peanut allergens and symptom severity is currently unclear.
Objective To determine if the pattern of IgE binding to specific peanut allergens is associated with the severity of clinical symptoms.
Methods Forty peanut allergic patients underwent a double-blind placebo-controlled low-dose peanut challenge, during which the severity of the patients' peanut allergy was scored. Serum peanut-specific IgE (psIgE) was measured and IgE binding patterns to peanut proteins analysed.
Results Seventeen IgE binding bands were identified between 5 and 100 kDa with eight bound by >50% of patients. The total number of bands per patient correlated significantly with challenge score (P=0.001, r=0.505) and psIgE (P<0.001, r=0.820). Cluster analysis failed to reveal any association between a particular protein or pattern of proteins (based on presence/absence) and challenge score. However, two protein bands (43 and 41 kDa) had peak intensities that correlated positively with challenge score and a third band (48 kDa) that correlated negatively. The bands were identified as subunits of Ara h 3/4 and 1, respectively.
Conclusions Promiscuity of IgE binding appears more important than the recognition of individual proteins. This may mean that clinically useful specific immunotherapy for peanut allergy will be difficult to achieve if only selected allergenic proteins are used. Further investigation of Ara h 1 and 3/4 subunits and a possible association with symptom severity are also highlighted by this study.
767-773
Lewis, S.A.
fb9dc5ac-21d9-4dfe-b917-fc87116170e2
Grimshaw, K.E.C.
766b6cf0-347a-447d-aeab-f07366f8ce28
Warner, J.O.
c232f1e5-62eb-46e6-8b0c-4836b45b36a5
Hourihane, J.O.B.
ece65177-9267-4011-84bd-fb8554ba892f
2005
Lewis, S.A.
fb9dc5ac-21d9-4dfe-b917-fc87116170e2
Grimshaw, K.E.C.
766b6cf0-347a-447d-aeab-f07366f8ce28
Warner, J.O.
c232f1e5-62eb-46e6-8b0c-4836b45b36a5
Hourihane, J.O.B.
ece65177-9267-4011-84bd-fb8554ba892f
Lewis, S.A., Grimshaw, K.E.C., Warner, J.O. and Hourihane, J.O.B.
(2005)
The promiscuity of immunoglobulin E binding to peanut allergens, as determined by Western blotting, correlates with the severity of clinical symptoms.
Clinical & Experimental Allergy, 35 (6), .
(doi:10.1111/j.1365-2222.2005.02252.x).
Abstract
Background IgE binding to a specific protein has been shown to be associated with severe anaphylaxis to hazelnuts; however, the relationship between IgE binding to specific peanut allergens and symptom severity is currently unclear.
Objective To determine if the pattern of IgE binding to specific peanut allergens is associated with the severity of clinical symptoms.
Methods Forty peanut allergic patients underwent a double-blind placebo-controlled low-dose peanut challenge, during which the severity of the patients' peanut allergy was scored. Serum peanut-specific IgE (psIgE) was measured and IgE binding patterns to peanut proteins analysed.
Results Seventeen IgE binding bands were identified between 5 and 100 kDa with eight bound by >50% of patients. The total number of bands per patient correlated significantly with challenge score (P=0.001, r=0.505) and psIgE (P<0.001, r=0.820). Cluster analysis failed to reveal any association between a particular protein or pattern of proteins (based on presence/absence) and challenge score. However, two protein bands (43 and 41 kDa) had peak intensities that correlated positively with challenge score and a third band (48 kDa) that correlated negatively. The bands were identified as subunits of Ara h 3/4 and 1, respectively.
Conclusions Promiscuity of IgE binding appears more important than the recognition of individual proteins. This may mean that clinically useful specific immunotherapy for peanut allergy will be difficult to achieve if only selected allergenic proteins are used. Further investigation of Ara h 1 and 3/4 subunits and a possible association with symptom severity are also highlighted by this study.
This record has no associated files available for download.
More information
Published date: 2005
Identifiers
Local EPrints ID: 27226
URI: http://eprints.soton.ac.uk/id/eprint/27226
ISSN: 0954-7894
PURE UUID: f85bcdfa-b9e5-48f7-bced-c7457780ccde
Catalogue record
Date deposited: 25 Apr 2006
Last modified: 15 Mar 2024 07:16
Export record
Altmetrics
Contributors
Author:
S.A. Lewis
Author:
J.O. Warner
Author:
J.O.B. Hourihane
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics